| Keyword | CPC | PCC | Volume | Score | Length of keyword |
|---|---|---|---|---|---|
| mannkind news | 0.96 | 0.7 | 8921 | 96 | 13 |
| mannkind | 0.89 | 0.6 | 8844 | 100 | 8 |
| news | 1.14 | 0.4 | 3728 | 6 | 4 |
| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| mannkind news | 1.63 | 0.4 | 2725 | 71 |
| mannkind news discussion | 0.77 | 0.3 | 2370 | 44 |
| mannkind news today | 1.54 | 0.1 | 6548 | 12 |
| mannkind news and rumors | 0.73 | 1 | 1522 | 75 |
| mannkind stock news | 0.33 | 0.5 | 5547 | 71 |
| breaking news mannkind corp | 1.16 | 1 | 4073 | 48 |
| mannkind corporation news | 0.86 | 0.8 | 3833 | 14 |
| mannkind afrezza latest news | 0.47 | 0.2 | 6941 | 13 |
| mannkind corporation latest news | 1.82 | 0.1 | 8228 | 2 |
| mannkind stock price news | 0.34 | 1 | 3632 | 23 |
| mannkind corp news | 0.39 | 0.7 | 7702 | 80 |
One share of MNKD stock can currently be purchased for approximately $5.03. How much money does MannKind make? MannKind (NASDAQ:MNKD) has a market capitalization of $1.32 billion and generates $75.44 million in revenue each year.
What did MannKind (mnkd) lose in the third quarter?Markets Stocks Indices Commodities Cryptocurrencies Currencies ETFs News (RTTNews) - MannKind Corp. (MNKD) revealed Loss for its third quarter that increased from the same period last year but beat the Street estimates. The company's earnings came in at -$14.43 million, or -$0.06 per share.
How many research reports have been made about MannKind?MannKind has only been the subject of 1 research reports in the past 90 days. MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States.
Where is MannKind Corporation headquartered?MannKind Corporation was incorporated in 1991 and is headquartered in Westlake Village, California. When Can We Expect A Profit From MannKind Corporation (NASDAQ:MNKD)?
